Kenya Vaccine Industry Outlook 2024 - 2028

See how Kenya Vaccine performed compared to key markets.

Key Market Indicators

Kenya's vaccination coverage for children aged one year is projected to reach 89% by 2028, up from 88% in 2023. This represents a compound annual growth rate (CAGR) of 0.2 percentage points. It is noteworthy that since 1989, Kenya's vaccination coverage has experienced a decline of 0.9 percentage points per year. In the realm of vaccine exports, Kenya saw a significant drop in 2018. The value of vaccine exports fell to approximately $4.4 million, down from $6.8 million in 2017, marking a decrease of 34.5% year-on-year. Since 1997, the country's vaccine supply has decreased by an average of 4.8% annually. Conversely, vaccine imports in Kenya saw an upward trend. In 2018, the value of vaccine imports rose to nearly $47.7 million, up from $43.4 million in 2017, reflecting a 10% increase from the previous year. Despite this growth, Kenya's demand for vaccines has actually decreased by 2.5% per year since 1997.

Kenya Vaccine Market Data and Forecasts

How much will Kenya Vaccine Market grow to 2028?

Forecast: Baccille Calmette Guérin Vaccine (BCG) Immunization Coverage in Kenya
Forecast: Diphtheria Tetanus Toxoid and Pertussis Third Dose (DTP3) Immunization Coverage in Kenya
Forecast: Baccille Calmette Guérin Vaccine (BCG) Immunization Coverage in Kenya
Forecast: Diphtheria Tetanus Toxoid and Pertussis Third Dose (DTP3) Immunization Coverage in Kenya
Forecast: Polio Vaccine Third Dose (Pol3) Immunization Coverage in Kenya

Other Top Countries about Vaccine